An independent life sciences cluster organisation based in Flanders, BelgiumMore info
ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder
2 hours ago
Confo Therapeutics awarded EUR 1.7M VLAIO grant to expand application of ConfoBody® drug discovery and development technology in rare diseases
Tuesday June 28th 2022
flanders.bio is a dynamic, member driven organisation with currently more than 340 members from Belgium and abroad. We help our members to create value by organising networking and training activities, supporting internationalisation, providing services and building expertise. flanders.bio and its members want to be the proud advocates of a reputable global-impact ecosystem in life sciences.
Platforms & Projects